Literature DB >> 234674

Mucosal-cell counts in ulcerative and granulomatous colitis.

S C Sommers, B I Korelitz.   

Abstract

Epithelial and connective-tissue cells were counted in rectal mucosal biopsies from 215 patients with ulcerative colitis, 98 patients with granulomatous colitis, and 50 controls. The results were analyzed statistically. Significantly decreased mucous goblet cells were found both in sigmoidoscopically abnormal ulcerative colitis and in granulomatous colitis, and they increased during the healing process. More pyknotic and karyorrhectic epithelial cells occurred in active ulcerative colitis than in granulomatous colitis. Inactive ulcerative colitis still manifested histologic evidence of acute and chronic inflammation, while sigmoidoscopically normal granulomatous colitis biopsies after previous gross rectal disease showed significantly increased macrophages in the lamina propria. Cell counts were valuable for differential diagnosis after the sigmoidoscopic appearance became normal. The acute inflammation of ulcerative colitis, as indicated by neutrophils, was decreased most notably following therapy with prednisone or 6-mercaptopurine. Chronic inflammation associated with fewer plasma cells was decreased after salicylazosulfapyridine as well as either of the other two drugs; macrophages, indicators of healing, increased most after 6-mercaptopurine combined with another anti-inflammatory agent.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 234674     DOI: 10.1093/ajcp/63.3.359

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

1.  Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and mucosal cell counts.

Authors:  B I Korelitz; S C Sommers
Journal:  Am J Dig Dis       Date:  1976-06

Review 2.  Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.

Authors:  J G Williams
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

3.  Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications.

Authors:  C A Seldenrijk; B C Morson; S G Meuwissen; N W Schipper; J Lindeman; C J Meijer
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

Review 4.  Histological healing in inflammatory bowel disease: a still unfulfilled promise.

Authors:  Vincenzo Villanacci; Elisabetta Antonelli; Karel Geboes; Giovanni Casella; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

5.  Mucin depletion in inflammatory bowel disease.

Authors:  D A McCormick; L W Horton; A S Mee
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

6.  A study of the histological criteria for ulcerative colitis: retrospective evaluation of multiple colonic biopsies.

Authors:  Y Konuma; M Tanaka; H Saito; A Munakata; Y Yoshida
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

Review 7.  Cell proliferation in gastrointestinal mucosa.

Authors:  W M Wong; N A Wright
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

8.  Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.

Authors:  Burton I Korelitz; Keith Sultan; Megha Kothari; Leo Arapos; Judy Schneider; Georgia Panagopoulos
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  Phagocytes in cell suspensions of human colon mucosa.

Authors:  W Beeken; I Northwood; C Beliveau; D Gump
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

10.  Microscopic activity in ulcerative colitis: what does it mean?

Authors:  S A Riley; V Mani; M J Goodman; S Dutt; M E Herd
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.